Equity Analysis /
Bangladesh

BANGLADESH PHARMA: Full valuations already reflect strong story; we prefer Square (Hold) to Beximco (Sell)

    Waseem Khan
    Waseem Khan

    Equity Research Analyst, Financials, Consumer and Pharmaceuticals (Bangladesh)

    Tellimer Research
    6 March 2018
    Published by